$ROL

ROLLINS INC

No enriched coverage for $ROL in the last 7 days.

No SEC Form 4 filings for $ROL in the last 30 days.

Med

Rollins shares drop 9.3% after Q2 earnings

Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.

UBS Sticks to Their Hold Rating for Rollins (ROL)

UBS analyst Joshua Chan reiterated a Hold rating on Rollins (ROL) and set a $43.00 price target. Other coverage cited includes Hold ratings from Canaccord Genuity and a Buy from Barclays. Rollins reported Q2 revenue of $1.08B and net profit of $143.91M, up from $999.53M revenue and $141.49M net profit a year earlier.

JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.

ROL sentiment & insider activity

Recent ROL coverage spans financial news, earnings and market movers.

What's driving ROL

  • Margin compression tied to a worsening lead environment and fewer digital pest-control searches increases near-term earnings risk.

    pluang.com · Jul 25, 2026

  • Analyst rating and price-target reiteration provides limited incremental information versus prior consensus, but can influence near-term sentiment.

    theglobeandmail.com · Jul 25, 2026

  • Analyst downgrade with sharply lower PT and revised revenue, EBITDA margin, and EPS estimates increases near-term downside risk for ROL sentiment and expectations.

    finance.yahoo.com · Jul 24, 2026

  • Street expectations for ROL were reset downward via a large price-target cut, adding pressure to near-term sentiment despite the overweight rating.

    marketbeat.com · Jul 24, 2026

  • Near-term demand volatility is weakening the prior overweight thesis.

    yahoo.com · Jul 24, 2026

alphai scores every news story that mentions ROL with an AI model for sentiment and relevance, and aggregates insider trades from ROLLINS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ROL

Score
$ROLMedAI 8/10

Rollins shares drop 9.3% after Q2 earnings

Rollins, Inc. reported Q2 2026 operating margin of 18.7%, down 110 bps year over year, and operating cash flow of $173 million, down 1.5%. CEO Jerry Gahlhoff said results missed expectations due to a weaker lead environment and fewer customers using digital pest-control searches. Rollins shares fell about 9.27%.

UBS Sticks to Their Hold Rating for Rollins (ROL)

UBS analyst Joshua Chan reiterated a Hold rating on Rollins (ROL) and set a $43.00 price target. Other coverage cited includes Hold ratings from Canaccord Genuity and a Buy from Barclays. Rollins reported Q2 revenue of $1.08B and net profit of $143.91M, up from $999.53M revenue and $141.49M net profit a year earlier.

JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, citing uncertainty from weakening residential demand and a slower margin recovery. It lowered fiscal 2026/2027 revenue growth forecasts to 8.7% and 8.4%, adjusted EBITDA margins to 21.9% and 22.2%, and adjusted EPS to $1.17 and $1.26. The move follows a weaker Q2 with declining lead volumes.

$PYPLMed

SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls

Wall Street analysts issued multiple rating changes. Truist upgraded PayPal (PYPL) to Hold, $57 target; Leerink upgraded Edwards Lifesciences (EW) to Outperform, $101. TD Cowen upgraded Digital Realty (DLR) to Buy, $222; Morgan Stanley upgraded Progressive (PGR) to Equal Weight, $210. Several downgrades followed, including Infosys (INFY) and Albertsons (ACI). Coverage initiations included SpaceX (SPCX) and Chime (CHYM).

$ROLMedAI 8/10

Rollins Analysts Cut Their Forecasts After Downbeat Q2 Earnings - Rollins (NYSE:ROL)

Rollins Inc (NYSE:ROL) reported Q2 results after the close. Earnings were 32 cents per share versus a 34-cent consensus, and sales were $1.079 billion versus $1.092 billion expected. Shares fell 1.7% to $38.78 premarket. After the report, JP Morgan cut its target to $45 from $70 and downgraded to Neutral, while Wells Fargo cut to $32 from $46 and downgraded to Underweight.

$ROLMed

Wells Fargo says ditch this pest control stock as demand continues to soften

Wells Fargo downgraded Rollins (ROL) to underweight from equal weight and cut its price target to $32 from $46, citing softer residential pest-control demand. The bank cited headwinds including weather, potential impacts from LLMs, more aggressive competition, and more price-sensitive consumers. Rollins reported 5.7% organic growth, missed Q2 estimates, and lowered FY2026 guidance to about 6%.

Related tickers